No Data
CNS: Supplementary explanation of the “Notice Concerning Revision of Dividend Forecasts (40th Anniversary of Founding)” dated 2025/4/17
CNS, Fanpep, and others.
＜4076＞CNS has revised its forecast, and the end-of-term Dividends per share is set at 75.00 yen, up from 49.00 yen (including a 40th Anniversary commemorative Dividends of 49.00 yen). ＜4258＞Amiya has finished the acquisition of its own shares. ＜4588＞OncoRis has obtained a business license for regenerative medicine product manufacturing and sales. ＜4881＞FanPep has started administering an allergy Vaccine to subjects in its clinical trials. ＜4890＞Tsubota Lab has commenced a domestic Phase II trial of TLM-003 targeted at myopia patients.
Kakaku.com ETC [Stocks with intriguing potential seen from Volume changes]
Closing price comparison with the previous day Volume * <9776> Sapporo 100,552,198,400 * <9240> Delivery Consultant 34,512,550,700 * <6074> JSS 41,514,134,400 * <6822> Oi Electric 273,219,884,000 * <3758> Aeria 25,124,654,400 * <4260> Hybrid Tech 46,769,202,300 * <7140> Petgo 89,129,135,400 * <4076> C.N.S 151,413,269,400 * <3
CNS: Notice regarding revisions to dividend forecasts (40th anniversary of establishment)
CNS: Summary of Financial Results for the 3rd Quarter Ending May 2025 [Japanese GAAP] (Consolidated)
CNS: Supplementary explanation of financial results for the 3rd quarter of the fiscal year ending May 2025
